chr20-23637679-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000099.4(CST3):āc.184A>Cā(p.Lys62Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000357 in 1,539,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000099.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CST3 | NM_000099.4 | c.184A>C | p.Lys62Gln | missense_variant | 1/3 | ENST00000376925.8 | NP_000090.1 | |
CST3 | NM_001288614.2 | c.184A>C | p.Lys62Gln | missense_variant | 1/4 | NP_001275543.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CST3 | ENST00000376925.8 | c.184A>C | p.Lys62Gln | missense_variant | 1/3 | 1 | NM_000099.4 | ENSP00000366124 | P1 | |
CST3 | ENST00000398411.5 | c.184A>C | p.Lys62Gln | missense_variant | 1/4 | 1 | ENSP00000381448 | P1 | ||
CST3 | ENST00000398409.1 | c.184A>C | p.Lys62Gln | missense_variant | 2/4 | 3 | ENSP00000381446 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000274 AC: 4AN: 145752Hom.: 0 AF XY: 0.0000387 AC XY: 3AN XY: 77498
GnomAD4 exome AF: 0.0000375 AC: 52AN: 1387566Hom.: 0 Cov.: 29 AF XY: 0.0000394 AC XY: 27AN XY: 684676
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 27, 2023 | The c.184A>C (p.K62Q) alteration is located in exon 1 (coding exon 1) of the CST3 gene. This alteration results from a A to C substitution at nucleotide position 184, causing the lysine (K) at amino acid position 62 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at